BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12637331)

  • 1. Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation.
    Thirukkumaran CM; Luider JM; Stewart DA; Cheng T; Lupichuk SM; Nodwell MJ; Russell JA; Auer IA; Morris DG
    Blood; 2003 Jul; 102(1):377-87. PubMed ID: 12637331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts.
    Thirukkumaran CM; Luider JM; Stewart DA; Alain T; Russell JA; Auer IA; Forsyth P; Morris DG
    Bone Marrow Transplant; 2005 Jun; 35(11):1055-64. PubMed ID: 15821774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reovirus as a successful ex vivo purging modality for multiple myeloma.
    Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
    Bone Marrow Transplant; 2014 Jan; 49(1):80-6. PubMed ID: 23974608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral purging of haematological autografts: should we sneeze on the graft?
    Thirukkumaran CM; Russell JA; Stewart DA; Morris DG
    Bone Marrow Transplant; 2007 Jul; 40(1):1-12. PubMed ID: 17450184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo purging of stem cell autografts using cytotoxic cells.
    Maki G
    J Hematother Stem Cell Res; 2001 Aug; 10(4):545-51. PubMed ID: 11522237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
    Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
    Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic methods of purging in autologous stem cell transplantation.
    Berkahn L
    J Hematother Stem Cell Res; 2000 Apr; 9(2):147-59. PubMed ID: 10813528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo purging with rituximab prior to collection of stem cells for autologous transplantation in chronic lymphocytic leukemia.
    Berkahn L; Simpson D; Raptis A; Klingemann HG
    J Hematother Stem Cell Res; 2002 Apr; 11(2):315-20. PubMed ID: 11983102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
    Isidori A; Motta MR; Tani M; Terragna C; Zinzani P; Curti A; Rizzi S; Taioli S; Giudice V; D'Addio A; Gugliotta G; Conte R; Baccarani M; Lemoli RM
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1224-32. PubMed ID: 17889360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma.
    Yang H; Robinson SN; Nieto Y; Jones RJ; Gocke CD; Lu J; Giralt SA; Jones RB; Decker WK; Xing D; Steiner D; Champlin RE; McMannis JD; Ng J; Thomas MW; Shah N; Andersson BS; Parmar S; Shpall EJ
    Cancer Res; 2011 Jul; 71(14):5040-9. PubMed ID: 21646477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
    Rahman MM; Madlambayan GJ; Cogle CR; McFadden G
    Cytokine Growth Factor Rev; 2010; 21(2-3):169-75. PubMed ID: 20211576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.
    Bartee E; Chan WM; Moreb JS; Cogle CR; McFadden G
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1540-51. PubMed ID: 22516053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ex vivo and in vivo purging for PBSCT].
    Moriyama Y
    Rinsho Byori; 1999 May; Suppl 110():79-84. PubMed ID: 10475035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma.
    Webb IJ; Friedberg nW; Gribben JG; Fisher DC; Spitzer T; Neuberg D; Jallow H; Kim H; Houde H; Monroy R; Schmittling R; Freedman AS
    Biol Blood Marrow Transplant; 2002; 8(8):429-34. PubMed ID: 12234168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+ subset and tumor cell quantitation by flow cytometry--step toward quality assessment of autografts in B cell malignancies.
    Johnsen HE; Rasmussen T; Knudsen LM
    Vox Sang; 1998; 74 Suppl 2():477-82. PubMed ID: 9704485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
    Klingemann HG; Wong E; Maki G
    Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device.
    Després D; Flohr T; Uppenkamp M; Baldus M; Hoffmann M; Huber C; Derigs HG
    J Hematother Stem Cell Res; 2000 Aug; 9(4):557-64. PubMed ID: 10982256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.